miR-145-5p and miR-203a-5p overcome imatinib resistance in myelogenous leukemic cells through metabolic reprogramming. IJBB [Internet]. 2023 Jun. 28 [cited 2026 Jul. 8];60(3):167-76. Available from: https://or.niscpr.res.in/index.php/IJBB/article/view/3345